A team of researchers at Oregon Health & Science University (OHUSU; Eugene) and Washington University (St. Louis) say they have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered – and patented – with potential to become a breakthrough drug for treating heart attacks and strokes.